(July 30, 2020 – Association of Clinical Research Professionals – ACRP Blog) As the world comes together to battle the COVID-19 pandemic, “people are rooting for clinical trials and the clinical trial professionals who make them possible,” says Pete Fronte, CEO at Altura. “This is a challenging and rewarding time for clinical research, as a few hundred thousand people will be needed for studies by the end of the year to bring forth a vaccine and other interventions quickly.”
Altura is collaborating with ACRP to offer its HCP Studies™ mobile platform for listing and finding trials, free to all ACRP members/study sites, as part of a broader effort to attack COVID-19 and help sites address enrollment delays for studies in other important areas such as cancer, neurology, and mental health. Since an estimated 200,000 clinical trials have been impacted with delays globally, many important non-COVID-19 studies will also need to address enrollment issues. A patient-focused version is also available at no cost. Users can easily view studies, share studies, and contact site teams as needed. For those who would like to add studies, please e-mail [email protected]. To learn more and to get download options, go to https://alturastudies.com/hcp-studies/. SEE MORE: ACRP Blog
